Association between low-dose glucocorticoid administration during anesthesia induction and neurological improvement in patients with spinal dural arteriovenous fistula: a propensity score–matched cohort study
European Spine Journal · 16.11.2026
DOI: 10.1007/s00586-026-10501-6 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift European Spine Journal, online erschienen am 16.11.2026. Verfasst von Huishen Pang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Xuan Wu Hospital of the Capital Medical University, Beijing, China. Die Arbeit nennt 42 Literaturangaben.
Abstract (Originalsprache)
Background
High-dose glucocorticoid treatment before the diagnosis of spinal dural arteriovenous fistula (SDAVF) has been associated with acute neurological worsening, but the association of a single, comparatively low dose administered during anesthesia induction with long-term neurological recovery remains uncertain. We evaluated the association between glucocorticoid administration during anesthesia induction and neurological improvement after definitive treatment.
Methods
This retrospective single-center cohort included patients with angiographically confirmed SDAVF treated between March 2013 and July 2021. Neurological improvement was defined as a decrease of at least 1 point in the modified Aminoff–Logue Scale score from pretreatment to the last follow-up. Patients were matched 1:1 without replacement and exactly by treatment modality using propensity scores based on age, sex, disease duration, and pretreatment neurological function. Between-group differences were evaluated using the paired risk difference, exact McNemar test, and modified Poisson regression. Glucocorticoid type and equivalent dexamethasone dose (EDD) were also evaluated among glucocorticoid-treated patients.
Results
The cohort included 428 patients, of whom 172 received glucocorticoids and 256 did not. Propensity-score matching retained 167 pairs. Neurological improvement occurred in 118 of 167 patients (70.7%) in the glucocorticoid group and 119 of 167 patients (71.3%) in the nonglucocorticoid group. The paired risk difference was − 0.6 percentage points (95% confidence interval [CI], − 10.4 to 9.2; exact McNemar P = 1.000). Glucocorticoid administration was not associated with neurological improvement in the adjusted modified Poisson model (risk ratio [RR], 0.996; 95% CI, 0.871–1.138; P = 0.947), and sensitivity analyses yielded consistent findings. Among matched glucocorticoid-treated patients, neither glucocorticoid type (dexamethasone vs. methylprednisolone: adjusted RR, 0.979; 95% CI, 0.666–1.441; P = 0.916) nor EDD (per 5-mg increase: adjusted RR, 1.022; 95% CI, 0.931–1.121; P = 0.646) was associated with neurological improvement.
Conclusion
A single, comparatively low glucocorticoid dose administered during anesthesia induction was not associated with neurological improvement at the last follow-up after definitive treatment of SDAVF. No clear associations were identified for glucocorticoid type or EDD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, Xuan Wu Hospital of the Capital Medical University, Beijing, China.
- Department of Anesthesiology, Xuan Wu Hospital of the Capital Medical University, Beijing, China.
- Department of Neurosurgery/Neuro-oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.
- Department of Neurosurgery, Xuan Wu Hospital of the Capital Medical University, Beijing, China. xwzhanghq@163.com.
- Department of Anesthesiology, Xuan Wu Hospital of the Capital Medical University, Beijing, China. w_tl5595@hotmail.com.
- Department of Neurosurgery, Xuan Wu Hospital of the Capital Medical University, Beijing, China. mayongjiedoctor@sina.com.
ORCID-Profile: Huishen Pang, Shubin Zhan, Zihao Song, Xin Su, Tao Hong, Hongqi Zhang
Zitieren
APA
Pang, H., Zhao, B., Zhan, S., Yang, C., Song, Z., Su, X., Chen, Y., Liu, H., Hong, T., Hu, P., Zhang, H., Wang, T., & Ma, Y. (2026). Association between low-dose glucocorticoid administration during anesthesia induction and neurological improvement in patients with spinal dural arteriovenous fistula: a propensity score–matched cohort study. European Spine Journal. https://doi.org/10.1007/s00586-026-10501-6
Vancouver
Pang H, Zhao B, Zhan S, Yang C, Song Z, Su X, et al. Association between low-dose glucocorticoid administration during anesthesia induction and neurological improvement in patients with spinal dural arteriovenous fistula: a propensity score–matched cohort study. European Spine Journal. 2026. doi:10.1007/s00586-026-10501-6
BibTeX
@article{Pang2026,
author = {Pang, Huishen and Zhao, Beichuan and Zhan, Shubin and Yang, Chengbin and Song, Zihao and Su, Xin and Chen, Yiguang and Liu, Huiwei and Hong, Tao and Hu, Peng and Zhang, Hongqi and Wang, Tianlong and Ma, Yongjie},
title = {Association between low-dose glucocorticoid administration during anesthesia induction and neurological improvement in patients with spinal dural arteriovenous fistula: a propensity score–matched cohort study},
journal = {European Spine Journal},
year = {2026},
doi = {10.1007/s00586-026-10501-6}
}
EUVIMED